Metal Reaction (Metal Hypersensitivity) - A Complete Guide

What Is a Metal Reaction?

"Allergic contact dermatitis (ACD) is a cell-mediated (type IV), delayed type, hypersensitivity reaction caused by skin contact with an environmental allergen. Prior sensitization is required for allergy to develop." - Fitzpatrick's Dermatology, 5e

Causative Metals

Pathophysiology (Mechanism)

Phase 1 - Sensitization (10-25 days, asymptomatic)

1. Keratinocytes release pro-inflammatory cytokines: IL-1, IL-8, IL-18, TNF-α, and GM-CSF
2. Langerhans cells (epidermal dendritic cells) and dermal dendritic cells take up the hapten-protein complex
3. These antigen-presenting cells migrate via lymphatics to regional lymph nodes
4. In lymph nodes, they present the antigen on MHC class II molecules to naïve CD4+ T cells (and MHC class I to CD8+ T cells)
5. Naïve T cells are primed, differentiate into memory effector T cells (Th1/Tc1), clonally expand, acquire skin-homing antigens, and enter circulation

"The sensitization phase generally lasts 10 to 25 days and often is asymptomatic." - Fitzpatrick's Dermatology, 5e

Phase 2 - Elicitation (Re-exposure: symptoms in 12-72 hours)

1. Low-grade non-specific inflammation activates toll-like receptors
2. Neutrophils are recruited first, then antigen-specific effector T cells are recruited to the skin
3. Effector T cells recognize the hapten-antigen complex presented by local Langerhans/dendritic cells
4. T cells release IFN-γ and TNF-α, stimulating macrophages and keratinocytes to release more cytokines
5. Monocytes migrate in, mature into activated macrophages, attracting more T cells
6. Visible inflammatory response (eczema, vesicles, edema) develops, typically peaking at 48-72 hours

DTH Response Mechanism Diagrams

Metal Implant-Specific Mechanism

Signs and Symptoms

Cutaneous (Skin Contact - Most Common)

• Pruritus (itching) - the cardinal symptom, often the first complaint
• Erythema (redness) at the contact site
• Edema (swelling) of affected skin
• Vesicles - small fluid-filled blisters
• Eczematous dermatitis - weeping, crusting plaques
• Scaling and fissuring in chronic cases
• Lichenification - thickened, leathery skin with prolonged exposure
• Hyperpigmentation or hypopigmentation (post-inflammatory)

• Earlobes, neckline, wrist, periumbilical area - nickel from jewelry, belt buckles
• Hands - occupational chromium/nickel (cement workers, hairdressers)
• Neck - necklaces, perfume atomizers in sensitized patients ("atomizer sign")
• Oral mucosa - dental metal alloys (contact stomatitis)

Systemic Symptoms (Implant/Systemic Exposure)

• Joint pain, swelling, stiffness around prosthetic implants
• Effusions (excess fluid in joint)
• Impaired wound healing at surgical site
• Aseptic loosening of implant (bone resorption via osteoclast activation)
• Pseudotumor / Metallosis - solid or cystic masses near prosthesis (ALVAL: aseptic lymphocyte-dominated vasculitis-associated lesion)
• Systemic contact dermatitis - distant skin rash from systemically absorbed metal (e.g., from metal-on-metal hip)
• Generalized weakness and fatigue (rare, severe cases)

Metal-Specific Cutaneous Signs (from Dermatology 5e, Table 88.12):

Causes and Risk Factors

Direct Causes

• Costume and cheap jewelry (earrings, rings, necklaces, belt buckles) - especially low-quality alloys high in nickel
• Occupational metal exposure - cement workers (chromium), hairdressers (nickel in dyes), metalworkers, welders, electronics workers
• Body piercing - early-age ear piercing dramatically increases nickel sensitization risk
• Orthopedic and dental implants - prosthetic hips/knees, cardiac stents, pacemaker leads, dental fillings
• Medical devices - IUDs (copper), orthodontic braces

Risk Factors

• Female sex - higher rates of nickel allergy linked to ear piercing practices
• Atopic history (asthma, atopic dermatitis, seasonal allergies)
• Previous sensitization - once sensitized, re-exposure causes reaction
• Occupation - construction, dentistry, hairdressing, manufacturing
• Genetic factors - polymorphisms in TNF, CLDN1, FLG genes increase susceptibility (as shown below)

Diagnosis

1. Clinical History

• Pattern and location of rash corresponding to metal contact sites
• Jewelry/piercing history, occupation, recent implant surgery
• Timing: delayed onset (12-72 hours after contact)

2. Epicutaneous Patch Testing (Gold Standard)

• Patch test panels (e.g., TRUE Test, North American Contact Dermatitis Group series) applied to the back for 48 hours, read at 48 and 72-96 hours
• Positive reaction = erythema + induration at the test site
• Identifies the specific metal(s) responsible
• Essential for patients with persistent/recurrent dermatitis

"Patch testing is the diagnostic test of choice to identify causal allergens and is indicated for patients with persistent or recurrent dermatitis in whom ACD is suspected." - Fitzpatrick's Dermatology, 5e

3. Spot Chemical Tests

• Dimethylglyoxime (DMG) test for nickel: detects nickel release from objects (pink precipitate = positive)
• 2-nitroso-1-naphthol-4-sulfonic acid spot test for cobalt

4. Blood Tests

• Lymphocyte transformation test (LTT) - useful for implant-related sensitivity
• Serum cobalt/chromium ion levels (for metal-on-metal implant assessment)

Prevention

Primary Prevention (Avoiding Sensitization)

1. Avoid nickel-releasing jewelry - choose surgical steel, titanium, 14-karat gold, platinum, or sterling silver
2. Legislation and regulation - the EU limits nickel release from skin-contact items to ≤0.5 μg/cm²/week (≤0.2 μg/cm²/week for piercing jewelry); similar policies should be adopted globally
3. Delay ear piercing in children to reduce sensitization risk
4. Pre-operative patch testing before joint replacement surgery if metal allergy is suspected - guides selection of hypoallergenic implant materials
5. Occupational protection - wear protective gloves, barrier creams (e.g., zinc oxide), and protective clothing when handling metals; adequate ventilation for metal fumes
6. Use nickel-free tools and equipment in sensitization-prone occupations

Secondary Prevention (Avoiding Elicitation Once Sensitized)

1. Strict allergen avoidance - coat metal items with clear nail polish or protective tape
2. Dietary nickel restriction in patients with systemic nickel allergy syndrome (avoid chocolate, coffee, instant tea, soybeans, whole grains, peanuts, legumes)
3. Hypoallergenic implant selection - titanium, zirconia, or coated alloys for patients with known metal sensitivity
4. Barrier emollients before occupational exposure

"To prevent development of nickel sensitivity, the European Union, in 1994, regulated the amount of nickel that may be released from objects with direct and prolonged skin contact to ≤0.5 μg nickel/cm²/week... Among Danish women, the prevalence of nickel allergy decreased from 28% in 1985 to 17% in 2007." - Fitzpatrick's Dermatology, 5e

Treatment

1. Allergen Avoidance (Mainstay)

"Allergen avoidance is the mainstay of ACD treatment. Educating patients about avoiding the allergen and related substances, and providing suitable alternatives, are crucial to a good outcome." - Fitzpatrick's Dermatology, 5e

2. Topical Corticosteroids

• First-line pharmacological treatment for mild-moderate ACD
• Potency selected based on body site (lower potency for face/flexures, higher for palms/soles)
• A 21-day course of topical corticosteroids at the cutaneous reaction site is effective in many implant-related cases
• Reduce inflammation, pruritus, and vesiculation

3. Systemic Corticosteroids

• For severe, widespread, or refractory ACD
• Oral prednisone (typically 0.5-1 mg/kg/day tapered over 2-3 weeks)
• Used when topical therapy is insufficient

4. Antihistamines

• Oral antihistamines for symptom relief, primarily for pruritus
• Note: antihistamines treat symptoms but do NOT address the underlying Type IV mechanism (unlike Type I allergy)
• Non-sedating antihistamines (cetirizine, loratadine) for daytime use
• Sedating antihistamines (hydroxyzine) for nighttime itch/sleep disruption

5. Calcineurin Inhibitors (Topical Immunomodulators)

• Tacrolimus ointment and pimecrolimus cream as steroid-sparing alternatives
• Particularly useful for facial/eyelid involvement or prolonged treatment to avoid steroid side effects

6. Emollients and Barrier Repair

• Moisturizers restore the skin barrier, reduce transepidermal water loss, and minimize allergen penetration
• Essential adjunct in all stages of ACD treatment

7. Wet Dressings / Compresses

• Cool, moist compresses for acute weeping vesicular reactions
• Reduce inflammation and provide symptomatic relief

8. Treatment for Implant-Related Reactions

• Topical/systemic corticosteroids as first step for peri-implant cutaneous reactions
• Implant removal if the implant has served its purpose and reaction is persistent
• Implant revision to non-allergenic materials (titanium alloy, ceramic, polytetrafluoroethylene-coated) - reserved for confirmed, refractory cases
• Revision surgery carries significant risks and unpredictable outcomes and is considered a last resort

9. Phototherapy

• Narrowband UVB or PUVA for chronic, widespread refractory cases
• Induces tolerance by promoting regulatory T cells

10. Systemic Immunosuppressants

• For severe chronic refractory ACD: azathioprine, methotrexate, cyclosporine, or mycophenolate mofetil
• Reserved for cases unresponsive to corticosteroids

Summary Table

• Fitzpatrick's Dermatology, 5e - Chapters on Allergic Contact Dermatitis and Mucocutaneous Findings with Heavy Metals
• Janeway's Immunobiology, 10e - Chapter 14: Hypersensitivity Reactions (Type IV)
• Dermatology 2-Volume Set, 5e - Table 88.12: Mucocutaneous Findings Associated with Toxic Elements and Heavy Metals
• PMC: Hypersensitivity to Orthopedic Implants